Clinical Trial Update: Hypertension in Breast Cancer Patients Receiving Bevacizumab

View source ↗

Summary

A terminated breast cancer trial evaluating bevacizumab reported hypertension as an adverse event.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Status: TERMINATED